Hopper Biotechnology
Latest round
- Angel
Last raised
- Aug 2024
Total raised
- Undisclosed
Investors
- 2
About Hopper Biotechnology
Established in 2022 and based in Shanghai, China, Hopper Biotechnology is a developer of 3D organ modeling and organ-on-a-chip technology for the discovery and validation of new targets in the preclinical phase of drug discovery and metabolic analysis of drug candidates. The company's founders are from Karolinska Institutet, Sweden, and China Pharmaceutical University, and one of the co-founders, Tingting Zhou, is a Master of Medical Informatics from Karolinska Institutet with more than ten years of incubation and investment experience in the biopharmaceutical field. The company has entered into partnerships with Merck, Eli Lilly and other companies. The company is committed to the research and development of 3D organ models and organ-on-a-chip technology, and has developed many 3D in vitro models, including liver, intestines, blood-brain barrier, nerves, and tumors. These 3D organ models can be used in conjunction with animal testing to evaluate and validate drug safety and efficacy. The company generates revenue by developing 3D organ modeling and organ-on-a-chip technology to provide drug companies with safety and efficacy monitoring of drugs.
Who invested in Hopper Biotechnology
2 investors across 1 round
See all investors in Hopper Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Aug 26, 2024
Amount
Undisclosed
Investors
Questions about Hopper Biotechnology
Who invested in Hopper Biotechnology?
Hopper Biotechnology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hopper Biotechnology raised?
Hopper Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hopper Biotechnology last raise money?
Hopper Biotechnology's most recent round on record is a Angel, in Aug 2024.
What does Hopper Biotechnology do?
Established in 2022 and based in Shanghai, China, Hopper Biotechnology is a developer of 3D organ modeling and organ-on-a-chip technology for the discovery and validation of new targets in the preclinical phase of drug discovery and metabolic analysis of drug candidates.
Where is Hopper Biotechnology headquartered?
Hopper Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Hopper Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at Hopper Biotechnology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Angel
Raising like Hopper Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.